Piramal Pharma (NSE:PPLPHARMA) Long-Term Capital Lease Obligation : ₹1,180 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Long-Term Capital Lease Obligation?

Piramal Pharma's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹1,180 Mil.

Piramal Pharma's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₹956 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹1,180 Mil).

Piramal Pharma's annual Long-Term Capital Lease Obligation increased from Mar. 2022 (₹862 Mil) to Mar. 2023 (₹1,019 Mil) and increased from Mar. 2023 (₹1,019 Mil) to Mar. 2024 (₹1,180 Mil).

Piramal Pharma Long-Term Capital Lease Obligation Historical Data

The historical data trend for Piramal Pharma's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Long-Term Capital Lease Obligation Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

73.70

862.00

1,019.20

1,179.90

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial							1,019.20	-	956.10	-	1,179.90

Piramal Pharma (NSE:PPLPHARMA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Piramal Pharma Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines